Concepedia

Margaret Porter

MP

11

Publications

811

Citations

10

H-Index

1992

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

State University of New York

Stony Brook University

Rockefeller University

Howard Hughes Medical Institute

Margaret Porter is an author at Vertex Pharmaceuticals (United States) specializing in medicine, biochemistry, and molecular biology.

Top concepts

Publications per year

1992–2000

11

Publications

11

A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase

Ted Fox, Joyce T. Coll, Xiaoling Xie et al. · Protein Science · 1998 · 135 citations · Full text

Reciprocal Regulation of Hck Activity by Phosphorylation of Tyr527 and Tyr416

Margaret Porter, Thomas H. Schindler, John Kuriyan et al. · Journal of Biological Chemistry · 2000 · 116 citations · Full text

Improving SH3 domain ligand selectivity using a non-natural scaffold

Jack Nguyen, Margaret Porter, Mehran Amoui et al. · Chemistry & Biology · 2000 · 116 citations · Full text

, , +2

Plasmin Cleavage of the Amyloid β-Protein:  Alteration of Secondary Structure and Stimulation of Tissue Plasminogen Activator Activity

William E. Van Nostrand, Margaret Porter · Biochemistry · 1999 · 112 citations

Intramolecular Regulatory Interactions in the Src Family Kinase Hck Probed by Mutagenesis of a Conserved Tryptophan Residue

Michelle LaFevre-Bernt, Frank Sicheri, Alexander R. Pico et al. · Journal of Biological Chemistry · 1998 · 101 citations · Full text

Rows per page

1–5 of 11